The eCOA business claims to provide clinical expertise, especially in the areas of psychiatry, neuropathic pain.

Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into ...

Clinical trial tech company Clario has sealed its second acquisition in a week, doubling down further on neuroscience by ...

Tech firm Clario is boosting its electronic clinical outcome assessment (eCOA) offerings by acquiring the ...

La empresa tecnológica refuerza su plataforma de evaluación electrónica de resultados clínicos con capacidades avanzadas en ...

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience Electronic clinical outcomes assessments (eCOA ...

"WCG's eCOA expertise and capabilities in subjective endpoints are a strategic and complementary fit with Clario's endpoint solutions. This transaction allows WCG to focus on being a trusted ...